Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cx157 (1 trial)
fluoxetine (prozac) (1 trial)
naltrexone (revia) (1 trial)
Compulsive Personality Disorder (Phase 2)
Depression (Phase 2)
Depressive Disorder (Phase 2)
Depressive Disorder, Treatment-Resistant (Phase 2)
Disease (Phase 2)
Obsessive-Compulsive Disorder (Phase 2)
Trials (2 total)
Trial APIs (3 total)